APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Parathyroid Hormone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Human Parathyroid Hormone Industry Growth and Trends Forecast to 2032

20 December 202598 pages

Choose your research edition.

Industry ResearchRecombinant Human Parathyroid Hormone Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Parathyroid Hormone Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Recombinant Human Parathyroid Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Parathyroid Hormone Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Parathyroid Hormone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Recombinant Human Parathyroid Hormone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Human Parathyroid Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Parathyroid Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Parathyroid Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Parathyroid Hormone include Takeda, Shandong Buchang Pharmaceuticals, Beijing SL Pharmaceutical, NPS Pharma(Shire) and Ascendis Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Human Parathyroid Hormone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Human Parathyroid Hormone market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Human Parathyroid Hormone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Human Parathyroid Hormone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Human Parathyroid Hormone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Human Parathyroid Hormone Market by Company

Takeda

Shandong Buchang Pharmaceuticals

Beijing SL Pharmaceutical

NPS Pharma(Shire)

Ascendis Pharma

Recombinant Human Parathyroid Hormone Segment by Type

75 mcg/dose

50 mcg/dose

25 mcg/dose

100 mcg/dose

Recombinant Human Parathyroid Hormone Segment by Application

Postmenopausal Women with Osteoporosis

Hypocalcemia in Patients with Hypoparathyroidism

Recombinant Human Parathyroid Hormone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Parathyroid Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Parathyroid Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Parathyroid Hormone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Parathyroid Hormone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Human Parathyroid Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 75 mcg/dose Table 2. Major Company of 50 mcg/dose Table 3. Major Company of 25 mcg/dose Table 4. Major Company of 100 mcg/dose Table 5. Global Recombinant Human Parathyroid Hormone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (k units) Table 7. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type (2021-2026) Table 8. Global Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (US$ Million) Table 9. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type (2021-2026) Table 10. Global Recombinant Human Parathyroid Hormone Price by Type (2021-2026) & (US$/unit) Table 11. Global Recombinant Human Parathyroid Hormone Sales by Type (2027-2032) & (k units) Table 12. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type (2027-2032) Table 13. Global Recombinant Human Parathyroid Hormone Sales by Type (2027-2032) & (US$ Million) Table 14. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type (2027-2032) Table 15. Global Recombinant Human Parathyroid Hormone Price by Type (2027-2032) & (US$/unit) Table 16. North America Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (k units) Table 17. North America Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (k units) Table 19. Europe Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (k units) Table 23. Latin America Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Type (2021-2026) & (US$ Million) Table 26. Recombinant Human Parathyroid Hormone Industry Trends Table 27. Recombinant Human Parathyroid Hormone Industry Drivers Table 28. Recombinant Human Parathyroid Hormone Industry Opportunities and Challenges Table 29. Recombinant Human Parathyroid Hormone Industry Restraints Table 30. Global Recombinant Human Parathyroid Hormone Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company (2021-2026) Table 32. Global Recombinant Human Parathyroid Hormone Sales by Company (2021-2026) & (k units) Table 33. Global Recombinant Human Parathyroid Hormone Sales Share by Company (2021-2026) Table 34. Global Recombinant Human Parathyroid Hormone Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Recombinant Human Parathyroid Hormone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Recombinant Human Parathyroid Hormone Major Company Production Sites and Headquarters Table 37. Global Recombinant Human Parathyroid Hormone Company, Product Type & Application Table 38. Global Recombinant Human Parathyroid Hormone Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Recombinant Human Parathyroid Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Recombinant Human Parathyroid Hormone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Recombinant Human Parathyroid Hormone Sales by Region (2021-2026) & (k units) Table 43. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Region (2021-2026) Table 44. Global Recombinant Human Parathyroid Hormone Sales by Region (2021-2026) & (US$ Million) Table 45. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Region (2021-2026) Table 46. Global Recombinant Human Parathyroid Hormone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Recombinant Human Parathyroid Hormone Sales by Region (2027-2032) & (k units) Table 48. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Region (2027-2032) Table 49. Global Recombinant Human Parathyroid Hormone Sales by Region (2027-2032) & (US$ Million) Table 50. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Region (2027-2032) Table 51. Global Recombinant Human Parathyroid Hormone Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Recombinant Human Parathyroid Hormone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (k units) Table 54. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application (2021-2026) Table 55. Global Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (US$ Million) Table 56. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application (2021-2026) Table 57. Global Recombinant Human Parathyroid Hormone Price by Application (2021-2026) & (US$/unit) Table 58. Global Recombinant Human Parathyroid Hormone Sales by Application (2027-2032) & (k units) Table 59. Global Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application (2027-2032) Table 60. Global Recombinant Human Parathyroid Hormone Sales by Application (2027-2032) & (US$ Million) Table 61. Global Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application (2027-2032) Table 62. Global Recombinant Human Parathyroid Hormone Price by Application (2027-2032) & (US$/unit) Table 63. North America Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (k units) Table 64. North America Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (k units) Table 66. Europe Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (k units) Table 70. Latin America Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Recombinant Human Parathyroid Hormone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Takeda Recombinant Human Parathyroid Hormone Product Portfolio Table 77. Takeda Recent Development Table 78. Shandong Buchang Pharmaceuticals Company Information Table 79. Shandong Buchang Pharmaceuticals Business Overview Table 80. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Portfolio Table 82. Shandong Buchang Pharmaceuticals Recent Development Table 83. Beijing SL Pharmaceutical Company Information Table 84. Beijing SL Pharmaceutical Business Overview Table 85. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Portfolio Table 87. Beijing SL Pharmaceutical Recent Development Table 88. NPS Pharma(Shire) Company Information Table 89. NPS Pharma(Shire) Business Overview Table 90. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Portfolio Table 92. NPS Pharma(Shire) Recent Development Table 93. Ascendis Pharma Company Information Table 94. Ascendis Pharma Business Overview Table 95. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Ascendis Pharma Recombinant Human Parathyroid Hormone Product Portfolio Table 97. Ascendis Pharma Recent Development Table 98. North America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 99. North America Recombinant Human Parathyroid Hormone Sales by Country (2021-2026) & (k units) Table 100. North America Recombinant Human Parathyroid Hormone Sales Market Share by Country (2021-2026) Table 101. North America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032) & (k units) Table 102. North America Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Country (2027-2032) Table 103. North America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Recombinant Human Parathyroid Hormone Market Share by Country (2021-2026) Table 106. North America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Recombinant Human Parathyroid Hormone Market Share Forecast by Country (2027-2032) Table 108. Europe Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 109. Europe Recombinant Human Parathyroid Hormone Sales by Country (2021-2026) & (k units) Table 110. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country (2021-2026) Table 111. Europe Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032) & (k units) Table 112. Europe Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Recombinant Human Parathyroid Hormone Market Share by Country (2021-2026) Table 116. Europe Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Recombinant Human Parathyroid Hormone Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Country (2021-2026) & (k units) Table 120. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032) & (k units) Table 122. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Recombinant Human Parathyroid Hormone Market Share by Country (2021-2026) Table 126. Asia-Pacific Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Recombinant Human Parathyroid Hormone Market Share Forecast by Country (2027-2032) Table 128. Latin America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Latin America Recombinant Human Parathyroid Hormone Sales by Country (2021-2026) & (k units) Table 130. Latin America Recombinant Human Parathyroid Hormone Sales Market Share by Country (2021-2026) Table 131. Latin America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032) & (k units) Table 132. Latin America Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Recombinant Human Parathyroid Hormone Market Share by Country (2021-2026) Table 136. Latin America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Recombinant Human Parathyroid Hormone Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2021-2026) & (k units) Table 140. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032) & (k units) Table 142. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Recombinant Human Parathyroid Hormone Market Share by Country (2021-2026) Table 146. Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Recombinant Human Parathyroid Hormone Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Recombinant Human Parathyroid Hormone Distributors List Table 151. Recombinant Human Parathyroid Hormone Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Recombinant Human Parathyroid Hormone Image Figure 2. Global Recombinant Human Parathyroid Hormone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Parathyroid Hormone Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Parathyroid Hormone Sales (2021-2032) & (k units) Figure 5. 75 mcg/dose Image Figure 6. Global 75 mcg/dose Sales YoY Growth (2021-2032) & (k units) Figure 7. 50 mcg/dose Image Figure 8. Global 50 mcg/dose Sales YoY Growth (2021-2032) & (k units) Figure 9. 25 mcg/dose Image Figure 10. Global 25 mcg/dose Sales YoY Growth (2021-2032) & (k units) Figure 11. 100 mcg/dose Image Figure 12. Global 100 mcg/dose Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Recombinant Human Parathyroid Hormone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Recombinant Human Parathyroid Hormone Market Share by Type 2025 VS 2032 Figure 15. North America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2025 Figure 16. North America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2025 Figure 17. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2025 Figure 18. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2025 Figure 21. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Recombinant Human Parathyroid Hormone Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Postmenopausal Women with Osteoporosis Image Figure 28. Global Postmenopausal Women with Osteoporosis Sales YoY Growth (2021-2032) & (k units) Figure 29. Hypocalcemia in Patients with Hypoparathyroidism Image Figure 30. Global Hypocalcemia in Patients with Hypoparathyroidism Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Recombinant Human Parathyroid Hormone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Recombinant Human Parathyroid Hormone Market Share by Application 2025 VS 2032 Figure 33. North America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2025 Figure 34. North America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2025 Figure 35. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2025 Figure 36. Europe Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2025 Figure 39. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share in Value by Application in 2025 Figure 43. North America Recombinant Human Parathyroid Hormone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Recombinant Human Parathyroid Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Recombinant Human Parathyroid Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Recombinant Human Parathyroid Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Human Parathyroid Hormone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Recombinant Human Parathyroid Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Recombinant Human Parathyroid Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Recombinant Human Parathyroid Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Recombinant Human Parathyroid Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Recombinant Human Parathyroid Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Recombinant Human Parathyroid Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Human Parathyroid Hormone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Recombinant Human Parathyroid Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Recombinant Human Parathyroid Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Recombinant Human Parathyroid Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Recombinant Human Parathyroid Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Recombinant Human Parathyroid Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Recombinant Human Parathyroid Hormone Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Recombinant Human Parathyroid Hormone Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 75 mcg/dose
  • 50 mcg/dose
  • 25 mcg/dose
  • 100 mcg/dose
Applications
  • Postmenopausal Women with Osteoporosis
  • Hypocalcemia in Patients with Hypoparathyroidism
Companies covered
  • Takeda
  • Shandong Buchang Pharmaceuticals
  • Beijing SL Pharmaceutical
  • NPS Pharma(Shire)
  • Ascendis Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human Parathyroid Hormone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Human Parathyroid Hormone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Human Parathyroid Hormone Market by Type
  6. 1.3.1 75 mcg/dose
  7. 1.3.2 50 mcg/dose
  8. 1.3.3 25 mcg/dose
  9. 1.3.4 100 mcg/dose
  10. 1.4 Global Recombinant Human Parathyroid Hormone Market Size by Type
  11. 1.4.1 Global Recombinant Human Parathyroid Hormone Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Recombinant Human Parathyroid Hormone Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Recombinant Human Parathyroid Hormone Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Recombinant Human Parathyroid Hormone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Human Parathyroid Hormone Industry Trends
  2. 2.2 Recombinant Human Parathyroid Hormone Industry Drivers
  3. 2.3 Recombinant Human Parathyroid Hormone Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Parathyroid Hormone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Human Parathyroid Hormone Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Human Parathyroid Hormone Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Human Parathyroid Hormone Price (2021-2026)
  4. 3.4 Global Recombinant Human Parathyroid Hormone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Parathyroid Hormone Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Human Parathyroid Hormone Company, Product Type & Application
  7. 3.7 Global Recombinant Human Parathyroid Hormone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Parathyroid Hormone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Parathyroid Hormone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Parathyroid Hormone Tier 1, Tier 2, and Tier 3
4 Recombinant Human Parathyroid Hormone Regional Status and Outlook
  1. 4.1 Global Recombinant Human Parathyroid Hormone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Human Parathyroid Hormone Historic Market Size by Region
  3. 4.2.1 Global Recombinant Human Parathyroid Hormone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Human Parathyroid Hormone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Human Parathyroid Hormone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Human Parathyroid Hormone Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Human Parathyroid Hormone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Human Parathyroid Hormone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Human Parathyroid Hormone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Human Parathyroid Hormone by Application
  1. 5.1 Recombinant Human Parathyroid Hormone Market by Application
  2. 5.1.1 Postmenopausal Women with Osteoporosis
  3. 5.1.2 Hypocalcemia in Patients with Hypoparathyroidism
  4. 5.2 Global Recombinant Human Parathyroid Hormone Market Size by Application
  5. 5.2.1 Global Recombinant Human Parathyroid Hormone Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant Human Parathyroid Hormone Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant Human Parathyroid Hormone Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant Human Parathyroid Hormone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Recombinant Human Parathyroid Hormone Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Shandong Buchang Pharmaceuticals
  8. 6.2.1 Shandong Buchang Pharmaceuticals Company Information
  9. 6.2.2 Shandong Buchang Pharmaceuticals Business Overview
  10. 6.2.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Portfolio
  12. 6.2.5 Shandong Buchang Pharmaceuticals Recent Developments
  13. 6.3 Beijing SL Pharmaceutical
  14. 6.3.1 Beijing SL Pharmaceutical Company Information
  15. 6.3.2 Beijing SL Pharmaceutical Business Overview
  16. 6.3.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Portfolio
  18. 6.3.5 Beijing SL Pharmaceutical Recent Developments
  19. 6.4 NPS Pharma(Shire)
  20. 6.4.1 NPS Pharma(Shire) Company Information
  21. 6.4.2 NPS Pharma(Shire) Business Overview
  22. 6.4.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Portfolio
  24. 6.4.5 NPS Pharma(Shire) Recent Developments
  25. 6.5 Ascendis Pharma
  26. 6.5.1 Ascendis Pharma Company Information
  27. 6.5.2 Ascendis Pharma Business Overview
  28. 6.5.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Portfolio
  30. 6.5.5 Ascendis Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Human Parathyroid Hormone Sales by Country
  2. 7.1.1 North America Recombinant Human Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Human Parathyroid Hormone Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Human Parathyroid Hormone Market Size by Country
  6. 7.2.1 North America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Human Parathyroid Hormone Sales by Country
  2. 8.1.1 Europe Recombinant Human Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Human Parathyroid Hormone Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Human Parathyroid Hormone Market Size by Country
  6. 8.2.1 Europe Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Human Parathyroid Hormone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Human Parathyroid Hormone Sales by Country
  2. 10.1.1 South America Recombinant Human Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Human Parathyroid Hormone Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Human Parathyroid Hormone Market Size by Country
  6. 10.2.1 South America Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Human Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Human Parathyroid Hormone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Human Parathyroid Hormone Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Human Parathyroid Hormone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Human Parathyroid Hormone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Human Parathyroid Hormone Value Chain Analysis
  2. 12.1.1 Recombinant Human Parathyroid Hormone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Human Parathyroid Hormone Production Mode & Process
  7. 12.2 Recombinant Human Parathyroid Hormone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Human Parathyroid Hormone Distributors
  10. 12.2.3 Recombinant Human Parathyroid Hormone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst